Drug name - Eucrisa

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8039451 ANACOR PHARMS INC Boron-containing small molecules
Jun, 2029

(6 years from now)

CN101160124A ANACOR PHARMS INC Boron-Containing Small Molecules
Apr, 2011

(11 years ago)

CN101505603A ANACOR PHARMS INC Boron-Containing Small Molecules
Jul, 2012

(10 years ago)

CN101914109A ANACOR PHARMS INC Boron-Containing Small Molecules
Feb, 2026

(3 years from now)

CN102532180B ANACOR PHARMS INC Boron-Containing Small Molecules
Feb, 2026

(3 years from now)

CN101914109B ANACOR PHARMS INC Boron-Containing Small Molecules
Feb, 2026

(3 years from now)

CN102532180A ANACOR PHARMS INC Boron-Containing Small Molecules
Feb, 2026

(3 years from now)

IN200701176P3 ANACOR PHARMS INC Boron-Containing Small Molecules
Feb, 2026

(3 years from now)

IN265043B ANACOR PHARMS INC A Pharmaceutical Formulation Of Boron-Containing Small Molecules For Topical Application
Feb, 2026

(3 years from now)

EP2987796A1 ANACOR PHARMS INC Halogen-Substituted Boronophthalides For The Treatment Of Infections
Feb, 2026

(3 years from now)

EP3424932A1 ANACOR PHARMS INC Boronophthalides For Therapeutic Use
Feb, 2026

(3 years from now)

EP1853251B1 ANACOR PHARMS INC Halogen-Substituted Boronophthalides For The Treatment Of Infections
Feb, 2026

(3 years from now)

EP3424932B1 ANACOR PHARMS INC Boronophthalides For Therapeutic Use
Feb, 2026

(3 years from now)

EP1853251A4 ANACOR PHARMS INC Boron-Containing Small Molecules
Feb, 2026

(3 years from now)

EP2987796B1 ANACOR PHARMS INC Halogen-Substituted Boronophthalides For The Treatment Of Infections
Feb, 2026

(3 years from now)

EP1853251A2 ANACOR PHARMS INC Halogen-Substituted Boronophthalides For The Treatment Of Infections
Feb, 2026

(3 years from now)

EP2343304B1 ANACOR PHARMS INC Biocidal Boronophthalide Compounds
Feb, 2026

(3 years from now)

EP2343304A1 ANACOR PHARMS INC Biocidal Boronophthalide Compounds
Feb, 2026

(3 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8501712 ANACOR PHARMS INC Boron-containing small molecules as anti-inflammatory agents Feb, 2027

(4 years from now)

US9682092 ANACOR PHARMS INC Boron-containing small molecules as anti-inflammatory agents Feb, 2027

(4 years from now)

US9682092

(Pediatric)

ANACOR PHARMS INC Boron-containing small molecules as anti-inflammatory agents Aug, 2027

(4 years from now)

US8501712

(Pediatric)

ANACOR PHARMS INC Boron-containing small molecules as anti-inflammatory agents Aug, 2027

(4 years from now)

US8039451

(Pediatric)

ANACOR PHARMS INC Boron-containing small molecules Dec, 2029

(7 years from now)

US8168614 ANACOR PHARMS INC Boron-containing small molecules as anti-inflammatory agents Jan, 2030

(7 years from now)

US8168614

(Pediatric)

ANACOR PHARMS INC Boron-containing small molecules as anti-inflammatory agents Jul, 2030

(7 years from now)

Drugs and Companies using CRISABOROLE ingredient

Treatment: Method of treating mild to moderate atopic dermatitis.

Dosage: OINTMENT;TOPICAL

More Information on Dosage
Strength Dosage Availability
2% OINTMENT;TOPICAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.